A detailed history of Rakuten Securities, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Rakuten Securities, Inc. holds 45 shares of BIIB stock, worth $6,722. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Previous 50 10.0%
Holding current value
$6,722
Previous $11.6 Million 24.74%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$189.07 - $236.8 $945 - $1,184
-5 Reduced 10.0%
45 $8.72 Million
Q2 2024

Jul 31, 2024

SELL
$190.52 - $236.72 $1,714 - $2,130
-9 Reduced 15.25%
50 $11.6 Million
Q1 2024

May 01, 2024

BUY
$212.02 - $267.71 $2,120 - $2,677
10 Added 20.41%
59 $12.7 Million
Q4 2023

Jan 30, 2024

BUY
$222.59 - $267.94 $10,906 - $13,129
49 New
49 $12.7 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Rakuten Securities, Inc. Portfolio

Follow Rakuten Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rakuten Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rakuten Securities, Inc. with notifications on news.